Clearside Biomedical Inc. (CLSD) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Clearside Biomedical Inc.

NASDAQ: CLSD · Real-Time Price · USD
0.50
-0.04 (-7.20%)
At close: Jul 25, 2025, 3:59 PM

Clearside Biomedical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
1.43M 1.66M 7.7M 7.52M 8.45M 8.23M 2.21M 1.62M 984K 1.33M 26.68M 29.49M 29.89M 29.57M 3.9M 4.26M 3.83M
Cost of Revenue
149K 177K 48K 190K 403K 375K 559K 417K 242K 242K 3.93M 3.93M 3.89M 3.89M n/a n/a n/a
Gross Profit
1.28M 1.49M 7.66M 7.33M 8.05M 7.85M 1.65M 1.2M 742K 1.08M 22.76M 25.57M 26M 25.69M 3.9M 4.26M 3.83M
Operating Income
-25.88M -28.88M -24.65M -25.77M -25.45M -24.84M -30M -29.67M -30.24M -30.28M -3.5M -1.67M 76K -627K -26.44M -23.99M -23.45M
Interest Income
1.28M 1.46M 1.47M 1.54M 1.57M 1.72M 1.81M 1.4M 941K 449K n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-30.1M -34.35M -31.88M -33.46M -34.97M -32.48M -37.32M -35.88M -34.58M -32.95M -4.58M -1.64M 83K 376K -25.45M -22.99M -22.65M
Net Income
-30.81M -34.35M -31.88M -33.46M -34.97M -32.48M -36.24M -34.8M -33.48M -31.85M -4.55M -1.61M 85K 376K -25.45M -22.99M -22.65M
Selling & General & Admin
11.81M 11.81M 11.69M 11.48M 11.54M 11.87M 12.09M 11.81M 11.47M 11.77M 11.74M 12.2M 12.23M 11.66M 11.17M 10.73M 10.53M
Research & Development
17.44M 18.56M 20.61M 21.62M 21.96M 20.83M 19.56M 19.06M 19.55M 19.63M 18.44M 18.95M 17.58M 18.54M 19.17M 17.51M 16.75M
Other Expenses
248K -1.5M -1.14M -997K -539K 960K 1.05M 1.1M 667K 669K 222K 30K 7K 1M 999K 996K 798K
Operating Expenses
29.49M 30.37M 32.3M 33.24M 33.64M 32.84M 31.79M 30.87M 31.02M 31.4M 30.18M 31.16M 29.81M 30.2M 30.34M 28.24M 27.28M
Interest Expense
4.7M 9.78M 9.48M 9.64M 9.6M 9.36M 9.13M 7.8M 5.51M 3.34M 1.3M n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
22.11M 30.55M 32.35M 33.29M 33.9M 33.07M 32.21M 31.29M 31.22M 31.6M 30.18M 31.16M 29.81M 30.2M 30.34M 28.24M 27.28M
Income Tax Expense
715K n/a -6.58M -6.59M -3.84M -3.84M 1.66M 3.17M 392.67K 390.67K 1.47M -26K -2K n/a -44K -44K -44K
Shares Outstanding (Basic)
76.92M 75.85M 74.75M 74.73M 69.85M 62.4M 61.98M 61.65M 61.17M 60.41M 60.19M 60.1M 60.06M 59.67M 59.47M 57.75M 57.04M
Shares Outstanding (Diluted)
76.92M 75.85M 74.75M 74.73M 69.85M 62.4M 61.98M 61.65M 61.17M 60.41M 60.19M 60.15M 60.06M 61.18M 59.47M 57.75M 57.04M
EPS (Basic)
-0.41 -0.47 -0.45 -0.5 -0.55 -0.53 -0.59 -0.57 -0.55 -0.53 -0.08 -0.03 -0.01 -0.01 -0.46 -0.43 -0.45
EPS (Diluted)
-0.41 -0.47 -0.45 -0.5 -0.55 -0.53 -0.59 -0.57 -0.55 -0.53 -0.08 -0.03 -0.01 -0.01 -0.46 -0.43 -0.45
EBITDA
-20.22M -24.35M -22.23M -23.71M -25.29M -23.06M -28.12M -27.98M -28.96M -29.46M -3.11M -1.46M 259K -447K -26.27M -23.81M -23.27M
EBIT
-15.21M -24.57M -22.4M -23.81M -25.37M -23.13M -28.19M -28.08M -29.08M -29.61M -3.28M -1.64M 82K -623K -26.44M -23.99M -23.45M
Depreciation & Amortization
198K 226K 167K 108K 80K 67K 69K 92K 114K 145K 168K 173K 179K 178K 177K 179K 180K